Considering the higher incidence of heterozygous loss of BAP1 in individuals diagnosed with pancreatic ductal adenocarcinoma, we established a shBAP1 cell line to more accurately replicate the pathological state observed in PDAC patients (Supplementary Fig. S1D). The gene discussed is BAP1; the disease is pancreatic ductal adenocarcinoma.